HOTAIRM1 knock-down cells showed increased ROS levels compared to control cells (Fig. 3B), a finding in line with the proteogenomic results suggesting deficient mitochondrial function in HOTAIRM1 knock-down glioma cells. Here, HOTAIRM1 is linked to central nervous system cancer.